Insights & Resources

Weaver’s Q2 2025 SEC Update webinar summary covers transfer pricing strategies and financial reporting related to tariffs, as well as upcoming ASUs.

Weaver’s professionals discuss tax legislation and economic trends. Tips for audit and SOX compliance, M&A accounting as well as system implementations.

Although the SEC withdrew its climate disclosure rule, state and international regulations still require businesses to manage emissions and climate risks.

The FASB’s release of ASU 2024-03 is an important part of ensuring transparency and investor confidence when reading financial statements. Learn more.

The SEC’s new regulations for safeguarding crypto assets and the administration’s executive order are changing the landscape for digital assets.

J.P. Morgan’s Q3 2024 Biopharma Report highlights robust venture investments, shifting licensing trends and a resurgence in IPO activity.

This webinar summary covers changes to the TCJA, tax rates and credits, new requirements for ASC 280 and ASC 740 and year-end impairment reminders.

The Q3 2024 Medtech Report from J.P. Morgan spotlights heightened investments, mergers and public offerings, signaling a positive industry outlook.

Learn how ASU 2023-09 enhances income tax disclosures with new rate reconciliation and cash flow reporting requirements for public entities.

Weaver’s overview of the SEC’s 2025 examination priorities describe practices by investment advisers and others that may come under SEC review.

Weaver professionals discuss the U.S. Supreme Court’s decision to overturn the Chevron doctrine, cybersecurity and accounting reminders on goodwill impairment.

The home health and hospice sectors are facing significant challenges with personal care emerging as the key sector for mitigating risk.